? What Is The Oncomine CMML Panel Test?
The Oncomine CMML Panel is a cutting-edge next-generation sequencing (NGS) test that analyzes the genetic mutations associated with Chronic Myelomonocytic Leukemia (CMML). It provides a deep molecular understanding of the disease, helping doctors with accurate diagnosis, prognosis, and personalized treatment planning.

? Why Do People In Dubai Choose This Test?

✔️ Detects CMML-specific mutations such as TET2, SRSF2, ASXL1, RUNX1, NRAS, KRAS
✔️ Helps in early detection and accurate diagnosis
✔️ Guides treatment plans based on the genetic profile
✔️ Essential for prognostic stratification and monitoring disease progression
✔️ Trusted by Dubai’s leading hematologists and oncology centers

? Methodology Of The Test

1. Sample Collection:
   A blood sample or bone marrow aspirate is collected from the patient.

2. DNA Extraction:
   The genetic material is carefully extracted from the sample for molecular testing.

3. NGS Analysis:
   The DNA is sequenced using next-generation sequencing, targeting key CMML-related mutations.

4. Bioinformatics Interpretation:
   The data is analyzed using sophisticated tools to identify mutations, deletions, insertions, and gene expression changes.

5. Clinical Report:
   A detailed report is generated within 10–14 days, helping physicians determine the best treatment approach.

? Cost Of Oncomine CMML Panel In Dubai

The cost usually ranges between AED 3,500 – AED 6,500, based on the healthcare facility, complexity of genes analyzed, and whether genetic counseling is included.

? Where To Get This Test In Dubai

This advanced panel is available at:
• American Hospital Dubai
• Mediclinic City Hospital
• Al Zahra Hospital
• King’s College Hospital Dubai
• Emirates Specialty Hospital

?‍♀️ Frequently Asked Questions (FAQ)

Q1: What is CMML and why is genetic testing important?
CMML is a rare type of leukemia affecting blood-forming cells. Genetic testing helps in early detection, personalized treatment, and risk classification.

Q2: Which genes are typically mutated in CMML?
Common mutations include TET2, ASXL1, SRSF2, RUNX1, NRAS, KRAS, SETBP1, and others.

Q3: Is this test useful after treatment has started?
Yes, it helps assess treatment effectiveness and identify potential resistance mutations or disease progression.

Q4: Can the test be done from a blood sample?
Yes, in many cases a blood sample is sufficient. In some cases, a bone marrow sample may be required.

Q5: How long does it take to get the results?
Typically, the results are ready within 10 to 14 working days.

✅ Conclusion
The Oncomine CMML Panel Test is a powerful and precise diagnostic tool designed to support the early detection and management of Chronic Myelomonocytic Leukemia. With its deep molecular insight, it empowers doctors in Dubai to offer targeted, personalized treatments that improve patient outcomes. If you or a loved one are showing signs of CMML or require further evaluation, this test is a crucial step in the journey to better health. Book your test at a trusted Dubai facility today.